Tottori University Researchers Uncover New Insights in Cancer Therapy and Stem Cell Research

Researchers at Tottori University in Japan have made significant breakthroughs in cancer therapy and stem cell research, as published in recent studies in international journals. These findings have the potential to revolutionize the treatment of various diseases, including cancer.

Apoptosis and cell-cycle arrest in tumor cells are induced by adenovirus-mediated p53 A4 (Ad-p53 A4) mutant, a mutant p53 protein that is resistant to murine double minute 2-mediated degradation. According to A. Maeda and colleagues, Ad-p53 A4 infection at a low multiplicity of infection showed significant accumulation of p53 protein and strongly induced a killing effect on osteosarcoma cell line MG-63. The results suggest that Ad-p53 A4 has the ability to strongly suppress tumor cells and is a promising, novel tool for cancer gene therapy.

In another study, adenovirus-mediated thrombopoietin gene transfer stimulates oval cell proliferation in liver as well as increasing peripheral platelet counts. M. Ichiba and associates demonstrated that hepatic TPO mRNA peaked its expression at 2 days after gene transduction and then gradually decreased, while the peripheral platelet number began to increase at 4 days.

Additionally, ascorbic acid has been found to promote osteoclastogenesis from embryonic stem cells. M. Tsuneto and colleagues reported that the number of TRAP-positive cells was strongly increased by the addition of ascorbic acid during the development of osteoclast precursors, and reducing agents failed to substitute for ascorbic acid.

Key Takeaways:

• Adenovirus-mediated p53 A4 mutant induces apoptosis and cell-cycle arrest in tumor cells, suggesting a promising tool for cancer gene therapy.
• Adenovirus-mediated thrombopoietin gene transfer stimulates oval cell proliferation in liver and increases peripheral platelet counts.
• Ascorbic acid promotes osteoclastogenesis from embryonic stem cells through increasing Flk-1-positive cells.
• These findings have significant implications for the treatment of various diseases, including cancer, and may lead to the development of novel therapies.
• Researchers at Tottori University have made significant contributions to the field of cancer therapy and stem cell research, demonstrating the potential of adenovirus-mediated gene transfer and ascorbic acid in promoting cell differentiation.

Statistics:

• Ad-p53 A4 infection at a low multiplicity of infection showed significant accumulation of p53 protein, resulting in a killing effect on osteosarcoma cell line MG-63 (Maeda et al., 2006).
• Hepatic TPO mRNA peaked its expression at 2 days after gene transduction and then gradually decreased (Ichiba et al., 2005).
• The peripheral platelet number began to increase at 4 days after adenovirus-mediated thrombopoietin gene transfer (Ichiba et al., 2005).
• Ascorbic acid increased the total cell recovery and frequency of osteoclast precursors by 4 days (Tsuneto et al., 2005).
• The proportion of Flk-1-positive cells but not that of platelet-derived growth factor receptor alpha-positive cells was increased by the addition of ascorbic acid (Tsuneto et al., 2005).

Sources:

• Maeda, A., et al. (2006). Induction of efficient apoptosis and cell-cycle arrest in tumor cells by adenovirus-mediated p53 A4 mutant. Pathol Int, 56(3), 126-134.
• Ichiba, M., et al. (2005). Dual effects of adenovirus-mediated thrombopoietin gene transfer on hepatic oval cell proliferation and platelet counts. Biochem Biophys Res Commun, 335(3), 723-729.
• Tsuneto, M., et al. (2005). Ascorbic acid promotes osteoclastogenesis from embryonic stem cells. Biochem Biophys Res Commun, 335(4), 1239-1246.